Mark Lackner - Insider Trading & Ownership

Entity
Individual
Location
C/O Ideaya Biosciences, Inc., 7000 Shoreline Court, Suite 350, South San Francisco, CA
Summary
The estimated net worth of Mark Lackner is at least $2.26M dollars as of February 5, 2024. Mark Lackner is the Chief Scientific Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $2.26M.
All Insider Reports
All Insider Reports

Ownership of Mark Lackner

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Chief Scientific Officer $2.26M -$18.3K -0.8% Feb 1, 2024

Insider Transactions Reported by Mark Lackner:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.